神経ペプチドY受容体Y4アゴニストのパイプライン・インサイト2018

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMR2016497)
◆英語タイトル:Neuropeptide Y Receptor Y4 (NPY4R) Agonists -Pipeline Insights, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMR2016497
◆発行日:2019年05月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥137,500見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[神経ペプチドY受容体Y4アゴニストのパイプライン・インサイト2018]についてメールでお問い合わせはこちら
本調査レポートでは、世界における神経ペプチドY受容体Y4アゴニストのパイプライン動向について調査・分析し、以下の構成でお届けいたします。

・神経ペプチドY受容体Y4アゴニストの概要
・神経ペプチドY受容体Y4アゴニストのパイプライン概要
・企業別開発中の神経ペプチドY受容体Y4アゴニスト
・後期治験段階の薬剤(Filed & Phase III):比較分析
・中期治験段階の薬剤(Phase II):比較分析
・初期治験段階の薬剤(Phase I & IND Filed):比較分析
・薬剤候補のプロファイル
・神経ペプチドY受容体Y4アゴニストの評価
  - 単剤治療薬別評価
  - 併用治療薬別評価
  - 投与経路別評価
  - 分子種類別評価
・開発が中止された薬剤リスト
・開発休止中の薬剤リスト
・神経ペプチドY受容体Y4アゴニスト開発に取り組んでいる企業リスト
・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s, “Neuropeptide Y Receptor Y4 (NPY4R) Agonists-Pipeline Insights, 2018”, report provides in depth insights on the pipeline drugs and their development activities around the Neuropeptide Y Receptor Y4 (NPY4R) Agonists. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Neuropeptide Y Receptor Y4 (NPY4R) Agonists. DelveInsight’s Report also assesses the Neuropeptide Y Receptor Y4 (NPY4R) Agonists therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.


Scope
• The report provides competitive pipeline landscape of Neuropeptide Y Receptor Y4 (NPY4R) Agonists
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Neuropeptide Y Receptor Y4 (NPY4R) Agonists pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Neuropeptide Y Receptor Y4 (NPY4R) Agonists and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Overview
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Disease Associated
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Pipeline Therapeutics
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Therapeutics under Development by Companies
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Filed and Phase III Products
• Comparative Analysis
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Phase II Products
• Comparative Analysis
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Phase I and IND Filed Products
• Comparative Analysis
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists – Discontinued Products
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists – Dormant Products
• Companies Involved in Therapeutics Development for Neuropeptide Y Receptor Y4 (NPY4R) Agonists
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Neuropeptide Y Receptor Y4 (NPY4R) Agonists by Therapy Area, 2018
• Number of Products under Development for Neuropeptide Y Receptor Y4 (NPY4R) Agonists, 2018
• Number of Products under Development by Companies
• Comparative Analysis by Filed and Phase III Products, 2018
• Comparative Analysis Phase II Products, 2018
• Comparative Analysis Phase I and IND Filed Products, 2018
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2018
• Drug Candidates Profiles
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Assessment by Monotherapy Products
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Assessment by Combination Products
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Assessment by Route of Administration
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Assessment by Stage and Route of Administration
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Assessment by Molecule Type
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Assessment by Stage and Molecule Type
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Therapeutics – Discontinued Products
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Therapeutics – Dormant Products
• Products under Development by Companies, 2018


List of Figures
• Number of Products under Development for Neuropeptide Y Receptor Y4 (NPY4R) Agonists by Therapy Area, 2018
• Number of Products under Development for Neuropeptide Y Receptor Y4 (NPY4R) Agonists, 2018
• Filed and Phase III Products, 2018
• Phase II Products, 2018
• Phase I and IND Filed Products, 2018
• Discovery and Pre-Clinical Stage Products, 2018
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Assessment by Monotherapy Products
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Assessment by Combination Products
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Assessment by Route of Administration
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Assessment by Stage and Route of Administration
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Assessment by Molecule Type
• Neuropeptide Y Receptor Y4 (NPY4R) Agonists Assessment by Stage and Molecule Type


*** レポートのキーワード ***

神経ペプチドY受容体Y4アゴニスト、医薬品、製薬、研究開発、パイプライン、治療、治験

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • シリアの塩素酸塩、過塩素酸塩、臭素酸塩、過臭素酸塩、ヨウ素酸塩及び過ヨウ素酸塩市場2015
    The report presents analysis of chlorates and perchlorates, bromates and perbromates, iodates and periodates market in Syria. [Scope] Brief country profile includes general information and main economic indicators and specifies business environment in Syria Chlorates and Perchlorates, Bromates and P …
  • シリコーンゴム製電源ケーブルの日本市場(現状と見通し)
    The Silicone Rubber Power Cable market size will be XX million (USD) in 2022 in Japan, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Japan market, the top players include many company. With key sales data like sales (volume), revenue, market s …
  • Qumak S.A. (QMK):企業財務及びSWOT分析(IT・通信業界)
    Summary This comprehensive SWOT profile of Qumak S.A. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential oppor …
  • ソフトドリンク(飲料)市場(~2017):アイスランド
    Synopsis "Soft Drinks Market in Iceland: Databook to 2017" is the result of Canadean’s extensive market research covering the Soft Drinks market in Iceland. The report presents detailed historic and forecast data on the Soft Drinks consumption trends in Iceland, offering consumption volume and value …
  • アフリカのお菓子市場(Confectionery Products – African Markets Package)
    This market research report package offers a perspective on the actual market situation, trends and future outlook for confectionery products in different African countries. The studies provide essential market information for decision-makers including: - Overall market for confectionery products in …
  • スティル及びスパークリング・ワイン市場展望(~2018):タイ
    Summary - The Future of the Still and Sparkling Wine Market in Thailand to 2018 is the result of Canadean's extensive market research covering the Still and Sparkling Wine market in Thailand. - The report presents detailed data on the Still and Sparkling Wine consumption trends in Thailand, historic …
  • B型肝炎ワクチンの世界市場機会分析
    Hepatitis B virus (HBV) is transmitted by exposure to infectious blood or body fluids by percutaneous or mucosal means. Transmission occurs usually amongst adults exhibiting risk behaviours e.g. IDUs, MSM and heterosexuals with multiple partners although vertical transmission can occur from mother t …
  • 世界の砂糖市場2015
    The Global Sugar Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Sugar industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Sugar market analysis is p …
  • PLC Systems Inc. (PLCSF)(医療機器分野):企業M&A動向
    Summary PLC Systems Inc. (PLC) is a medical device manufacturer. The company develops products and technologies for the cardiac and vascular markets. Its product includes RenalGaurd. PLC’s RenalGaurd is a closed loop system that is designed to minimize the risk of over or under hydration. Its produc …
  • 世界及び中国のベンフォチアミン市場2009-2019
    Market Research Report on Global and Chinese Benfotiamine Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Benfotiamine industry. The report firstly reviews the basic information of Benfotiamine including its classification, application and manufacturing technol …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMR2016497 )"神経ペプチドY受容体Y4アゴニストのパイプライン・インサイト2018" (英文:Neuropeptide Y Receptor Y4 (NPY4R) Agonists -Pipeline Insights, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。